Tag: New Diagnosis
Ovarian cancer surveillance results in earlier diagnosis for women with faulty BRCA genes who want to defer surgeryNovember 1, 2022 4:17 pm
by British Medical Journal
Regularly monitoring women with faulty BRCA genes that make them highly susceptible to ovarian cancer results in earlier stage diagnosis in those who want to defer preventive surgery, finds research published online in the Journal of … Read more
Insurance Type Linked With Disparities in the Treatment of Gynecologic CancerOctober 14, 2022 10:36 am
by Jordyn Sava
In the interview with Targeted Oncology, Anna Jo Bodurtha Smith, MD, discusses the effects various insurance types have on the quality of care of patients with gynecologic cancers.Whether a patient with gynecologic cancer has insurance or is … Read more
Study could help recommend the best treatment for women with early-stage mucinous ovarian cancerOctober 12, 2022 1:23 pm
by Emily Henderson, B.Sc.
A global study into mucinous ovarian cancer could help oncologists recommend the best treatment for women who are diagnosed early with the condition.
By looking down a microscope for two different ‘patterns of invasion’ – the … Read more
Ovarian Cancer Detection Takes a Step ForwardSeptember 12, 2022 1:45 pm
A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot … Read more
Nonselective Beta-Blockers May Improve Outcomes in Ovarian CancerAugust 29, 2022 2:19 pm
by Charles Bankhead
Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed.
Two-year postoperative survival … Read more
Understanding the genetic testing-related information needs of ovarian cancer patientsJuly 29, 2022 11:45 am
Reviewed by Emily Henderson, B.Sc.
JMIR Publications recently published “Understanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study” in JMIR Cancer, which reported that experts in gynecological cancer care recommend that … Read more
Researchers Use US to Predict Ovarian CancerMarch 22, 2022 11:13 am
Approach can help radiologists in a busy clinical practice assess lesions more quickly
The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery, according to a new study published … Read more
Intraperitoneal Carboplatin Plus Paclitaxel Improves PFS in Ovarian Cancer, Yet OS Results Remain Unchanged Vs IV ChemoMarch 20, 2022 10:18 am
by Gina Mauro
The iPocc trial indicated that patients with ovarian cancer experienced an improvement in progression-free survival when treated with intraperitoneal carboplatin plus paclitaxel compared with intravenous chemotherapy, but this benefit did not translate to overall survival.
Paclitaxel Plus Carboplatin Is Reportedly Non-Inferior to Paclitaxel and Ifosfamide in Uterine CarcinosarcomaJanuary 13, 2022 8:49 am
by Ariana Pelosci
Findings from a phase 3 study indicated that patients with uterine carcinosarcoma treated with paclitaxel and carboplatin experienced a better progression-free survival and non-inferior duration of overall survival vs paclitaxel plus ifosfamide.
A combination regimen of paclitaxel… Read more
Not-So-Silent Early-Stage Ovarian CancerJanuary 6, 2022 11:11 am
by Charles Bankhead
— More than 70% of patients reported one or more symptoms prior to diagnosis
More than 70% of women with high-risk early ovarian cancer had one or more symptoms of underlying disease, most often abdominal or pelvic … Read more
Why Black women with ovarian cancer require greater focusDecember 15, 2021 9:55 am
by Sophia George
Providing equal access to care will not by itself equalize outcomes between Black and white women.
Women from the African diaspora are disproportionately affected by high-grade and aggressive ovarian tumours. In the United States, mortality due to … Read more
FDA approves pioneering drug for ovarian cancer surgeryNovember 29, 2021 10:11 am
by Steve Tally
Purdue-developed imaging drug allowed surgeons to find additional cancer lesions
Left image: A drug used for fluorescent imaging during ovarian cancer surgeries, which was just approved by the FDA, lights up cancer cells “like stars against a … Read more
A Better Option for Preserving Fertility in Gynecologic Cancer Patients?October 19, 2021 12:00 am
— In vitro maturation can result in both embryos and oocyte vitrification, researcher says
by Amanda D’Ambrosio
In vitro maturation of immature eggs may be an effective method of fertility preservation for patients with gynecologic cancers, according to a prospective … Read more
Neoadjuvant Chemo for Advanced Ovarian Cancer Reduced Short-Term MortalitySeptember 30, 2021 12:00 am
By Mike Bassett
— Programs frequently using this treatment achieved these declines without compromising OS
Cancer programs that were more likely to use neoadjuvant chemotherapy to treat advanced ovarian cancer saw larger declines in short-term mortality versus programs with less … Read more
Symptoms of Ovarian Cancer Explained as Woman Diagnosed Thanks to Small Navel GrowthSeptember 28, 2021 12:00 am
By Aatif Sulleyman
A woman is raising awareness of ovarian cancer and how difficult it can be to detect, having been diagnosed with the illness by a dermatologist who removed a small growth from her navel.
Despite being aware of … Read more
Novel vaccine safe, effective in ovarian cancer subsetJune 11, 2021 8:51 am
A novel vaccine appeared safe and demonstrated clinical benefit as front-line maintenance therapy for women with advanced-stage ovarian cancer, according to results of a phase 2b trial presented during the virtual ASCO Annual Meeting.… Read more
Pafolacianine Sodium, NIRF Imaging Adjunct May Yield Benefit in FR+ Ovarian CancerJune 8, 2021 11:16 am
Experts reveal pafolacianine sodium may offer a novel real-time adjunct to current surgical imaging practice in ovarian cancer surgery, according to a phase 3 study being presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.… Read more
No Difference in Survival Noted With Longer Duration of Bevacizumab for Ovarian CancerJune 7, 2021 11:18 am
Doubling treatment duration of bevacizumab did not lead to better survival in patients with ovarian cancer who were treated on a phase 3 trial.
For patients with primary epithelial ovarian, fallopian tube, or peritoneal cancer, prolonged treatment
Atezolizumab Regimen Fails to Extend PFS in Newly Diagnosed Ovarian CancerMay 24, 2021 3:00 pm
By Jennifer Southall
The addition of atezolizumab to chemotherapy and bevacizumab failed to significantly prolong PFS for women with newly diagnosed stage III or stage IV epithelial ovarian cancer, according to a phase 3 study in Journal of Clinical Oncology… Read more